Omnicell, Inc. (NASDAQ: OMCL) stock fell -0.33% on Monday to $33.00 against a previous-day closing price of $33.11. With 0.58 million shares changed hands, the volume of the stock remained lighter than its average volume of 0.75 million shares. During the session, the Health Information Services company that operates in wider Healthcare sector, reached to the highest price of $33.39 whereas the lowest price it dropped to was $32.60. The 52-week range on OMCL shows that it touched its highest point at $77.14 and its lowest point at $28.72 during that stretch. It currently has a 1-year price target of $39.33. Beta for the stock currently stands at 0.89.
Price Performance and Earnings:
Stock performance is one of the indicators that investors use to determine whether they will profit from a stock. The price performance of OMCL was up-trending over the past week, with a rise of 7.25%, but this was down by -16.73% over a month. Three-month performance dropped to -42.72% while six-month performance fell -55.79%. The stock lost -37.89% in the past year, while it has lost -34.55% so far this year. A look at the trailing 12-month EPS for OMCL yields -0.77 with Next year EPS estimates of 1.74. For the next quarter, that number is 0.16. This implies an EPS growth rate of -42.26% for this year and 0.54% for next year. EPS is expected to grow by 12.00% annually over the next five years; however, over the past five years, the company experienced an annual growth rate of -31.02%.
Float and Shares Shorts:
At present, 44.75 million OMCL shares are outstanding with a float of 44.55 million shares on hand for trading. On Oct 30, 2023, short shares totaled 2.52 million, which was 5.54% higher than short shares on Sep 28, 2023. In addition to Mr. Randall A. Lipps as the firm’s Founder, Executive Chairman, President & CEO, Mr. Corey J. Manley serves as its Executive VP and Chief Legal & Administrative Officer.
Other institutions hold 64.81% of OMCL, in contrast to 5.52% held by mutual funds. Shares owned by individuals account for 40.93%. As the largest shareholder in OMCL with 15.27% of the stake, BlackRock Fund Advisors holds 6,902,711 shares worth 6,902,711. A second-largest stockholder of OMCL, The Vanguard Group, Inc., holds 5,031,586 shares, controlling over 11.13% of the firm’s shares. Wellington Management Co. LLP is the third largest shareholder in OMCL, holding 2,337,755 shares or 5.17% stake. With a 6.73% stake in OMCL, the iShares Core S&P Small Cap ETF is the largest stakeholder. A total of 3,041,702 shares are owned by the mutual fund manager. The Vanguard Explorer Fund, which owns about 3.95% of OMCL stock, is the second-largest Mutual Fund holder. It holds 1,785,995 shares valued at 63.47 million. Vanguard Total Stock Market ETF holds 3.14% of the stake in OMCL, owning 1,420,524 shares worth 50.49 million.
Reading analyst opinions is an effective way to decide where to invest, and there are several opinions available for OMCL since 0 analysts follow the stock currently. In the same way, a target price assigned to a stock can also reveal much about its potential. With OMCL analysts setting a high price target of $50.00 and a low target of $28.00, the average target price over the next 12 months is $39.33. Based on these targets, OMCL could surge 51.52% to reach the target high and fall by -15.15% to reach the target low. Reaching the average price target will result in a growth of 19.18% from current levels.
Summary of Insider Activity:
Insiders traded OMCL stock several times over the past three months with 0 Buys and 2 Sells. In these transactions, 0 shares were bought while 166 shares were sold. The number of buy transactions has increased to 24 while that of sell transactions has risen to 27 over the past year. The total number of shares bought during that period was 164,370 while 60,551 shares were sold.